↓ Skip to main content

Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies

Overview of attention for article published in Frontiers in oncology, February 2022
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
75 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Targeting KRAS Mutant in Non-Small Cell Lung Cancer: Novel Insights Into Therapeutic Strategies
Published in
Frontiers in oncology, February 2022
DOI 10.3389/fonc.2022.796832
Pubmed ID
Authors

Anne-Laure Désage, Camille Léonce, Aurélie Swalduz, Sandra Ortiz-Cuaran

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 75 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 75 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 15%
Student > Bachelor 8 11%
Researcher 8 11%
Student > Master 8 11%
Other 4 5%
Other 4 5%
Unknown 32 43%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 13 17%
Medicine and Dentistry 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Agricultural and Biological Sciences 3 4%
Chemistry 3 4%
Other 2 3%
Unknown 38 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2022.
All research outputs
#16,135,410
of 25,604,262 outputs
Outputs from Frontiers in oncology
#5,565
of 22,741 outputs
Outputs of similar age
#234,772
of 449,897 outputs
Outputs of similar age from Frontiers in oncology
#362
of 1,568 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,741 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,897 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,568 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.